BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28858767)

  • 1. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
    Chen G; Xiao B; Chen L; Bai B; Zhang Y; Xu Z; Fu L; Liu Z; Li X; Zhao Y; Liang G
    Eur J Med Chem; 2017 Oct; 139():726-740. PubMed ID: 28858767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
    Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G
    Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
    Chen G; Zhang Y; Liu X; Fang Q; Wang Z; Fu L; Liu Z; Wang Y; Zhao Y; Li X; Liang G
    J Med Chem; 2016 Mar; 59(6):2436-51. PubMed ID: 26937738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor.
    Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z
    Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
    Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G
    J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity.
    Zhang Y; Liu Z; Wu J; Bai B; Chen H; Xiao Z; Chen L; Zhao Y; Lum H; Wang Y; Zhang H; Liang G
    Eur J Med Chem; 2018 Mar; 148():291-305. PubMed ID: 29466778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
    Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G
    Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury.
    Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G
    Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury.
    Chen L; Chen H; Chen P; Zhang W; Wu C; Sun C; Luo W; Zheng L; Liu Z; Liang G
    Eur J Med Chem; 2019 Jan; 161():22-38. PubMed ID: 30342423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
    Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C
    Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
    Chen L; Fu W; Zheng L; Wang Y; Liang G
    Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2.
    Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X
    Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.
    Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y
    Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
    Xia Q; Bao X; Sun C; Wu D; Rong X; Liu Z; Gu Y; Zhou J; Liang G
    Eur J Med Chem; 2018 Dec; 160():120-132. PubMed ID: 30326372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Structure-Activity Relationship Analysis of Thiazolo[3,2-a]pyrimidine Derivatives with Anti-inflammatory Activity in Acute Lung Injury.
    Chen L; Jin Y; Fu W; Xiao S; Feng C; Fang B; Gu Y; Li C; Zhao Y; Liu Z; Liang G
    ChemMedChem; 2017 Jul; 12(13):1022-1032. PubMed ID: 28503918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2.
    Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G
    Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.
    Liu Z; Chen L; Yu P; Zhang Y; Fang B; Wu C; Luo W; Chen X; Li C; Liang G
    J Med Chem; 2019 Jun; 62(11):5453-5469. PubMed ID: 30998353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.